Vermont Diabetes Information System

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00109369
Recruitment Status : Completed
First Posted : April 27, 2005
Last Update Posted : February 1, 2011
Vermont Program for Quality in Health Care
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary:
The Vermont Diabetes Information System (VDIS) is a registry-based decision support and reminder system based on the Chronic Care Model and targeted to primary care physicians and their patients with diabetes. It will be evaluated by a randomized, controlled study in 60 Primary Care practices in Vermont and nearby New York.

Condition or disease Intervention/treatment
Diabetes Mellitus Other: Information and decision support for providers and patients

Detailed Description:

The long-term goal of the Vermont Diabetes Information System is to reduce morbidity and mortality from diabetes mellitus. The project will implement and evaluate a state-wide system to support evidence-based disease management by primary care providers, their practices, and their patients in the community. The primary study question is: "What is the effect of a Diabetes Information System (including education, feedback and decision support) upon disease control measured by glycated hemoglobin?" Secondary questions address the effect of the system upon adherence to guideline recommendations, blood pressure control, patient satisfaction, medication use, and functional status. We hypothesize that the information system will result in improvements in the process and outcomes of clinical care. There are two specific aims:

Aim 1: Implement the Diabetes Information System. Objective 1.1: Develop a registry of patients with diabetes in primary care practices in Vermont; Objective 1.2: Provide education and feedback to providers regarding their patients with diabetes; Objective 1.3: Deliver decision support (flow sheets, alerts and reminders) based on the registry and targeted at primary care providers and patients, to prompt ideal management of diabetes.

Aim 2: Assess the Diabetes Information System. Objective 2.1: Assess disease control and guideline adherence by examining registry data in all subjects in a prospective, two-year, randomized, controlled trial in 60 primary care practices; Objective 2.2: Assess outcomes (blood pressure control, obesity, functional status, symptoms, medication use, and satisfaction) by interview and examination in a sub-sample of patients from the controlled trial.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 7500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Vermont Diabetes Information System
Study Start Date : June 2003
Study Completion Date : December 2007

Arm Intervention/treatment
Experimental: Active
Provider and patient receive Diabetes Information System services
Other: Information and decision support for providers and patients
Laboratory-based decision support, reminders, and population report cards.
Other Name: Vermedx Diabetes Information System
No Intervention: Control
Usual Care

Primary Outcome Measures :
  1. Glycemic control [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Processes of care [ Time Frame: 2 years ]
  2. Blood pressure control [ Time Frame: 2 years ]
  3. Hypercholesterolemia [ Time Frame: 2 years ]
  4. Adherence to Practice Guidelines [ Time Frame: 2 years ]
  5. Quality of life [ Time Frame: 2 years ]
  6. Healthcare utilization [ Time Frame: 2 years ]
  7. Patient satisfaction [ Time Frame: 2 years ]
  8. Medication use [ Time Frame: 2 years ]
  9. Functional status [ Time Frame: 2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Adult
  • Diabetes confirmed by Primary Care provider

Exclusion Criteria:

  • Severe dementia
  • Nursing home resident

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00109369

United States, Vermont
University of Vermont
Burlington, Vermont, United States, 05401
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Vermont Program for Quality in Health Care
Principal Investigator: Benjamin Littenberg, MD University of Vermont
Study Director: Charles D. MacLean, MDCM University of Vermont

Responsible Party: Benjamin Littenberg, Professor, University of Vermont Identifier: NCT00109369     History of Changes
Other Study ID Numbers: 61167 (completed)
R01DK061167 ( U.S. NIH Grant/Contract )
K24DK068380 ( U.S. NIH Grant/Contract )
First Posted: April 27, 2005    Key Record Dates
Last Update Posted: February 1, 2011
Last Verified: January 2011

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Chronic Disease
Multi-Hospital Information Systems
Clinical Decision Support Systems
Reminder Systems
Quality of Healthcare
Guideline Adherence
Outcome and Process Assessment (Health Care)
Technology Assessment, Biomedical
Primary Health Care

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases